(VIANEWS) – Eli Lilly and Company (LLY), Enova International (ENVA), Royal Caribbean Cruises (RCL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Eli Lilly and Company (LLY)
21.6% sales growth and 46.46% return on equity
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; Foghorn Therapeutics Inc., and PRISM BioLab Co.,Ltd. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Earnings Per Share
As for profitability, Eli Lilly and Company has a trailing twelve months EPS of $5.49.
PE Ratio
Eli Lilly and Company has a trailing twelve months price to earnings ratio of 114.19. Meaning, the purchaser of the share is investing $114.19 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 46.46%.
Sales Growth
Eli Lilly and Company’s sales growth is 22.3% for the present quarter and 21.6% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Eli Lilly and Company’s EBITDA is 546.2.
2. Enova International (ENVA)
20.9% sales growth and 15.89% return on equity
Enova International, Inc., a technology and analytics company, provides online financial services in the United States, Brazil, Australia, and Canada. The company offers installment loans; line of credit accounts; receivables purchase agreements; CSO programs, including arranging loans with independent third-party lenders and assisting in the preparation of loan applications and loan documents; and bank programs, such as marketing services and loan servicing for near-prime unsecured consumer installment loan. It markets its financing products under the CashNetUSA, NetCredit, OnDeck, Headway Capital, The Business Backer, Simplic, and Pangea names. Enova International, Inc. was incorporated in 2011 and is headquartered in Chicago, Illinois.
Earnings Per Share
As for profitability, Enova International has a trailing twelve months EPS of $5.9.
PE Ratio
Enova International has a trailing twelve months price to earnings ratio of 9.33. Meaning, the purchaser of the share is investing $9.33 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.89%.
3. Royal Caribbean Cruises (RCL)
17.1% sales growth and 23.71% return on equity
Royal Caribbean Cruises Ltd. operates as a cruise company worldwide. The company operates cruises under the Royal Caribbean International, Celebrity Cruises, and Silversea Cruises brands, which comprise a range of itineraries. As of February 13, 2023, it operated 64 ships. The company was founded in 1968 and is headquartered in Miami, Florida.
Earnings Per Share
As for profitability, Royal Caribbean Cruises has a trailing twelve months EPS of $3.28.
PE Ratio
Royal Caribbean Cruises has a trailing twelve months price to earnings ratio of 38.36. Meaning, the purchaser of the share is investing $38.36 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.71%.
Sales Growth
Royal Caribbean Cruises’s sales growth is 28.6% for the present quarter and 17.1% for the next.
Moving Average
Royal Caribbean Cruises’s value is higher than its 50-day moving average of $115.36 and way above its 200-day moving average of $95.61.
4. Customers Bancorp (CUBI)
14.6% sales growth and 14.7% return on equity
Customers Bancorp, Inc. operates as the bank holding company for Customers Bank that provides financial products and services to individual consumers, and small and middle market businesses. It operates in two segments, Customers Bank Business Banking and BankMobile. The company accepts various deposit products, such as checking, savings, money market deposit, time deposit, non-interest-bearing demand accounts, individual retirement accounts, and other deposit accounts, as well as non-retail time deposits. It also provides commercial and industrial lending services; small business administration and paycheck protection program loans; multi-family and commercial real estate loans; commercial loans to mortgage companies; equipment financing services and specialty lending; mortgage warehouse loans; and home equity and residential mortgage and installment loans. In addition, the company offers private banking services; mobile phone banking, internet banking, wire transfers, electronic bill payment, lock box, remote deposit capture, courier, merchant processing, cash vault, controlled disbursements, and positive pay services; and cash management services, such as account reconciliation, collections, and sweep accounts. It operates 12 full-service branches, as well as limited production and administrative offices in Southeastern Pennsylvania, including Bucks, Berks, Chester, Philadelphia, and Delaware Counties; Rye Brook and New York; Hamilton, New Jersey; Boston, Massachusetts; Providence, Rhode Island; Portsmouth, New Hampshire; Manhattan and Melville, New York; Washington D.C.; and Chicago, Illinois. Customers Bancorp, Inc. was founded in 1997 and is headquartered in West Reading, Pennsylvania.
Earnings Per Share
As for profitability, Customers Bancorp has a trailing twelve months EPS of $6.32.
PE Ratio
Customers Bancorp has a trailing twelve months price to earnings ratio of 8.2. Meaning, the purchaser of the share is investing $8.2 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.7%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 128.6% and 8.4%, respectively.
Volume
Today’s last reported volume for Customers Bancorp is 553000 which is 57.86% above its average volume of 350300.
5. Curtiss (CW)
10.8% sales growth and 16.89% return on equity
Curtiss-Wright Corporation, together with its subsidiaries, designs, manufactures, and overhauls precision components, and engineered products and services primarily to the aerospace, defense, general industrial, and power generation markets worldwide. The company operates through three segments: Commercial/Industrial, Defense, and Power. The Commercial/Industrial segment offers industrial vehicle products, such as electronic throttle control devices, joysticks, and transmission shifters; sensors, controls and electro-mechanical actuation components used in commercial aircrafts; valves for use in the industrial markets; and surface technology services, including shot peening, laser peening, coatings, and advanced testing. The Defense segment provides commercial off-the-shelf embedded computing board-level modules, data acquisition and flight test instrumentation equipment, integrated subsystems, instrumentation and control systems, turret aiming and stabilization products, and weapons handling systems; avionics and electronics; and aircraft data management solutions to the commercial aerospace market. The Power segment offers hardware, pumps, pump seals, control rod drive mechanisms, valves, fastening systems, specialized containment doors, airlock hatches, spent fuel management products, and fluid sealing products for nuclear power plants and nuclear equipment manufacturers; and naval propulsion and auxiliary equipment, including coolant pumps, power-dense compact motors, generators, steam turbines, valves, and secondary propulsion systems, as well as ship repair and maintenance services primarily to the U.S. navy. Curtiss-Wright Corporation was founded in 1929 and is headquartered in Davidson, North Carolina.Curtiss-Wright Corporation, together with its subsidiaries, designs, manufactures, and overhauls precision components, and engineered products and services primarily to the aerospace, defense, general industrial, and power generation markets worldwide. The company operates through three segments: Commercial/Industrial, Defense, and Power. The Commercial/Industrial segment offers industrial vehicle products, such as electronic throttle control devices, joysticks, and transmission shifters; sensors, controls and electro-mechanical actuation components used in commercial aircrafts; valves for use in the industrial markets; and surface technology services, including shot peening, laser peening, coatings, and advanced testing. The Defense segment provides commercial off-the-shelf embedded computing board-level modules, data acquisition and flight test instrumentation equipment, integrated subsystems, instrumentation and control systems, turret aiming and stabilization products, and weapons handling systems; avionics and electronics; and aircraft data management solutions to the commercial aerospace market. The Power segment offers hardware, pumps, pump seals, control rod drive mechanisms, valves, fastening systems, specialized containment doors, airlock hatches, spent fuel management products, and fluid sealing products for nuclear power plants and nuclear equipment manufacturers; and naval propulsion and auxiliary equipment, including coolant pumps, power-dense compact motors, generators, steam turbines, valves, and secondary propulsion systems, as well as ship repair and maintenance services primarily to the U.S. navy. Curtiss-Wright Corporation was founded in 1929 and is headquartered in Davidson, North Carolina.
Earnings Per Share
As for profitability, Curtiss has a trailing twelve months EPS of $8.93.
PE Ratio
Curtiss has a trailing twelve months price to earnings ratio of 24.38. Meaning, the purchaser of the share is investing $24.38 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.89%.
6. Option Care Health (OPCH)
7.9% sales growth and 18.54% return on equity
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and others; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
Earnings Per Share
As for profitability, Option Care Health has a trailing twelve months EPS of $1.42.
PE Ratio
Option Care Health has a trailing twelve months price to earnings ratio of 22.56. Meaning, the purchaser of the share is investing $22.56 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.54%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.1%, now sitting on 4.21B for the twelve trailing months.
Yearly Top and Bottom Value
Option Care Health’s stock is valued at $32.03 at 15:22 EST, way below its 52-week high of $35.74 and way above its 52-week low of $24.23.
7. Betterware de Mexico, S.A.P.I de C.V. (BWMX)
7.6% sales growth and 80.96% return on equity
Betterware de México, S.A.P.I. de C.V. operates as a direct-to-consumer company. It operates through two segments, The Home Organization Products (Betterware or BWM); and The Beauty and Personal Care Products (JAFRA). The Betterware or BWM segment provides a portfolio of products comprising kitchen and food preservation; home solutions; bedroom; bathroom; laundry and cleaning; and technology and mobility. The JAFRA segment offers beauty and personal care products, such as fragrances; colors comprising cosmetics; skin care products; and toiletries. Betterware de México, S.A.P.I. de C.V. sells its products through catalogues, as well as distributes through a network of distributors, associates, leaders, and consultants to the end customers in Mexico and the United States. The company is headquartered in El Arenal, Mexico. Betterware de México, S.A.P.I. de C.V. is a subsidiary of Ebc Holdings, Inc.
Earnings Per Share
As for profitability, Betterware de Mexico, S.A.P.I de C.V. has a trailing twelve months EPS of $1.42.
PE Ratio
Betterware de Mexico, S.A.P.I de C.V. has a trailing twelve months price to earnings ratio of 8.61. Meaning, the purchaser of the share is investing $8.61 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 80.96%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 1.5%, now sitting on 12.84B for the twelve trailing months.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Nov 16, 2023, the estimated forward annual dividend rate is 0.88 and the estimated forward annual dividend yield is 7.07%.
Sales Growth
Betterware de Mexico, S.A.P.I de C.V.’s sales growth is 1% for the present quarter and 7.6% for the next.
Volume
Today’s last reported volume for Betterware de Mexico, S.A.P.I de C.V. is 47462 which is 15.06% below its average volume of 55883.
8. Columbus McKinnon Corporation (CMCO)
5.8% sales growth and 6.23% return on equity
Columbus McKinnon Corporation designs, manufactures, and markets intelligent motion solutions to ergonomically move, lift, position, and secure materials worldwide. The company offers electric, air-powered, lever, and hand hoists; hoist trolleys, explosion-protected and custom engineered hoists, and winches; crane systems, such as crane components and kits, enclosed track rail systems, mobile and jib cranes, and fall protection systems, as well as material handling solutions; rigging equipment comprising below-the-hook lifting devices, shackles, chains and chains accessories, forestry and hand tools, lifting slings, lashing systems, and tie-downs and load binders; rotary unions and swivel joints; and mechanical and electromechanical actuators. It also provides power and motion technology products, including AC motor controls and line regenerative systems, automation and diagnostics, brakes, cable and festoon systems, collision avoidance systems, conductor bar systems, DC motor and magnet control systems, elevator drives, inverter duty motors, mining drives, pendant pushbutton stations, radio controls, and wind inverters; power delivery subsystems; overhead aluminum light rail workstations; and low profile, flexible chain, large scale, sanitary, and vertical elevation conveyor systems, as well as pallet system conveyors and accumulation systems. The company serves market verticals, including general industries, transportation, energy and utilities, process industries, industrial automation, construction and infrastructure, food and beverage, entertainment, life sciences, consumer packaged goods, and e-commerce/supply chain/warehousing. It offers its products to end users directly, as well as through distributors, independent crane builders, material handling specialists and integrators, government agencies, original equipment manufacturers, and engineering procurement and construction firms. The company was founded in 1875 and is headquartered in Buffalo, New York.
Earnings Per Share
As for profitability, Columbus McKinnon Corporation has a trailing twelve months EPS of $1.77.
PE Ratio
Columbus McKinnon Corporation has a trailing twelve months price to earnings ratio of 20.88. Meaning, the purchaser of the share is investing $20.88 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.23%.
